Preparation of human dendritic cells for tumor vaccination.
Shurin
Michael R
MR
Clinical Immunopathology, University of Pittsburgh Medical Center, Cancer Institute, Pittsburgh, PA, USA.
D018952:Antigens, CD34 / Q000378:metabolism; D001773:Blood Cells / Q000166:cytology / Q000502:physiology; D019013:CD40 Antigens / Q000378:metabolism; D023201:CD40 Ligand / Q000378:metabolism; D019496:Cancer Vaccines / Q000378:metabolism*; D018929:Cell Culture Techniques / Q000379:methods; D002454:Cell Differentiation / Q000502:physiology; D003713:Dendritic Cells / Q000378:metabolism*; D006412:Hematopoietic Stem Cells / Q000502:physiology; D006801:Humans; D018189:Immunomagnetic Separation / Q000379:methods; D008264:Macrophages / Q000378:metabolism; D009369:Neoplasms / Q000378:metabolism; D012867:Skin / Q000166:cytology / Q000378:metabolism
D018952:Antigens, CD34; D019013:CD40 Antigens; D019496:Cancer Vaccines; D023201:CD40 Ligand